Back
Primoris Services 10K Form
Buy
66
PRIM
Primoris Services
Last Price:
$79.54
Seasonality Move:
4.29%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-09 | 10Q | PRIM/Primoris Services Quarterly |
2024-02-27 | 10K | PRIM/Primoris Services Annual |
2023-11-08 | 10Q | PRIM/Primoris Services Quarterly |
2023-08-08 | 10Q | PRIM/Primoris Services Quarterly |
2023-05-10 | 10Q | PRIM/Primoris Services Quarterly |
2023-02-28 | 10K | PRIM/Primoris Services Annual |
Receive PRIM News And Ratings
See the #1 stock for the next 7 days that we like better than PRIM
PRIM Financial Statistics
Sales & Book Value
Annual Sales: | $5.7B |
---|---|
Cash Flow: | $158.8M |
Price / Cash Flow: | 14.62 |
Annual Sales: | $25.28 |
Price / Book: | 3.15 |
Profitability
EPS (TTM): | 3.02000 |
---|---|
Net Income (TTM): | $164.6M |
Gross Margin: | $587.5M |
Return on Equity: | 12.98% |
Return on Assets: | 4.14% |
Primoris Services Earnings Forecast
Key Primoris Services Financial Ratios
-
The Gross Profit Margin over the past 16 years for PRIM is 10.28%.
-
The Selling, General & Administrative Expenses for PRIM have been equal to 5.75% of Gross Profit Margin.
-
The Interest Expense is 61.97% of Operating Income.
-
The Net Earning history of PRIM is 2.21% of Total Revenues.
-
Per Share Earnings over the last 17 years have been positive in 9 years.
Primoris Services Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Construction & Engineering |
Sector: | Industrials |
Current Symbol: | PRIM |
CUSIP: | 74164F |
Website: | prim.com |
Debt
Debt-to-Equity Ratio: | 0.67 |
---|---|
Current Ratio: | 1.38 |
Quick Ratio: | 1.3 |
Price-to-Earnings
Trailing P/E Ratio: | 34.16 |
---|---|
Forward P/E Ratio: | 17.18 |
PRIM Technical Analysis vs Fundamental Analysis
Buy
66
Primoris Services (PRIM)
is a Buy
Is Primoris Services a Buy or a Sell?
-
Primoris Services stock is rated a BuyThe current Primoris Services [PRIM] share price is $79.60. The Score for PRIM is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.